资讯 | 担忧财报及经济放缓 美股连续第二日收跌

wechat omage

美股

北京时间1月15日凌晨,美股周一收跌,主要股指连续第二个交易日下滑。美股财报季刚刚开始,对全球经济放缓、企业盈利下滑的担忧令市场承压。

道指跌86.11点,或0.36%,报23909.84点;标普500指数跌13.65点,或0.53%,报2582.61点;纳指跌65.56点,或0.94%,报6905.92点。

美国上市公司财报季从周一开始拉开帷幕。花旗集团(C)宣布业绩不及预期。JP摩根大通(JPM)、富国银行(WFC)、贝莱德(BLK)、高盛(GS)、Netflix(NFLX)及其他一些大企业将在本周陆续公布财报。

花旗集团的财报结果显示情况并不乐观。在第四季度,花旗最大的证券业务–固定收益交易营收锐减21%,降至七年来最低。股票和债券承销业务合计营收比分析师预期下降得更多。同时,花旗偏离全年盈利目标的幅度,比五周前暗示的程度更大。

而在第四季度财报季开始前,苹果(AAPL)及其他一些企业巨头相继发布的预警令投资者对企业盈利前景感到担忧。

焦点股关注:

花旗集团(C)收高,摆脱了第四财季营收不及预期的影响。

Lululemon Athletica(LULU)股价攀升,该公司宣布上调第四财季的盈利与营收预期。

天然气与电力公司太平洋瓦电(PCG)股价重挫。该公司表示计划在1月29日左右申请破产。

《今日美国》杂志的所有者Gannett(GCI)的股票攀升,此前私募股权公司MNG宣布收购该公司。

Goldcorp(G)股票交投活跃,此前纽蒙特矿业公司(NEM)表示计划以价值100亿美元的价格收购前者。 

   

港股

北京时间1月14日,上周中美谈判平稳过渡,美元连续破位下行,人民币大幅升值。中国周二公布的12月进出口数据显示,去年12月出口按年跌4.4%,进口则大减7.6%,两者均为逾两年以来最低表现。周二港股恒指低开低走,跌幅不断扩大。恒指收跌1.38%。

截至收盘,恒指收跌1.38%,报26298.33点,终结此前六连涨势头。恒生国企指数跌1.55%,报10299.44

热点板块:

三桶油、半导体、科技股领跌大市,中海油跌近5%,腾讯跌近3%。

资讯科技股全线走低,仁天科技跌10.77%,华虹半导体跌5.16%,美团点评跌3.52%,比亚迪电子5.79%,中国软件国际跌4.86%,中兴通讯跌3.25%,美图跌4.07%。

腾讯控股大跌2.84%,报价321.8港元,市值30636亿港元,沽空率超4成。港交所(00388)公布的沽空成交数据显示,腾讯全日沽空额12.96亿港元,全日维持此超高沽空比率水平,沽空率39.39%,成为2015年12月以来最高沽空比率。

小米股价跌3.09%,报价10.02港元。受禁售期届满影响,首只同股不同权股份小米(01810)股价表现反覆,投资者有人欢喜,有人愁。以上周五收市价计,7个基础投资者帐面蚀近17亿元;但市前投资者却帐赚近400亿元。

 

 

中国A股

北京时间1月14日,周一两市集体平开后逐渐下行,深成指和创业板指盘中双双跌超1%。早盘大幅高开的次新股逐渐杀跌,新疆交建午后封跌停上演天地板,市场人气萎靡,资金避险情绪升温推高黄金板块,受周末消息面提振,期货概念股早盘有所表现,但热度持续性不佳,周期股周一逆市大涨,5G概念股尾盘拉升。

截止收盘,沪指报2535.77点,下跌0.71%,成交额1162.43亿元;深成指报7409.20点,下跌0.87%,成交额1669.14亿元。

从盘面上看,工程机械、煤炭、钢铁涨幅居前;旅游、家居用品、医药、保险、酿酒、半导体、互联网等跌幅居前。

热点板块:

次新股周一早盘大幅高开,随后快速杀跌,午后新疆交建、爱朋医疗、西菱动力、泰永长征封死跌停,利通电子、资金银行、金力永磁等跌超8%。

周期股逆市走强,煤炭、钢铁板块携手大涨,云煤能源、美锦能源带领煤炭板块冲高,西宁特钢盘中快速涨停,带领钢铁板块迅速走强。 

如果有想了解更多全球股市资讯,请关注微信公众共 “辉立资本新加坡” (SGPSPL)

同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com